Avion Wealth’s Lexicon Pharmaceuticals LXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2K | Hold |
1,333
| – | – | ﹤0.01% | 883 |
|
|
2025
Q4 | $1K | Hold |
1,333
| – | – | ﹤0.01% | 1073 |
|
|
2025
Q3 | $1K | Hold |
1,333
| – | – | ﹤0.01% | 1049 |
|
|
2025
Q2 | $1K | Buy |
1,333
+199
| +18% | +$129 | ﹤0.01% | 1007 |
|
|
2025
Q1 | $0 | Buy |
+1,134
| New | +$715 | ﹤0.01% | 1226 |
|
|
2024
Q4 | – | Sell |
-407
| Closed | – | – | 1174 |
|
|
2024
Q3 | $0 | Hold |
407
| – | – | ﹤0.01% | 1206 |
|
|
2024
Q2 | $0 | Hold |
407
| – | – | ﹤0.01% | 1131 |
|
|
2024
Q1 | $1K | Hold |
407
| – | – | ﹤0.01% | 1005 |
|
|
2023
Q4 | $1K | Hold |
407
| – | – | ﹤0.01% | 866 |
|
|
2023
Q3 | $0 | Hold |
407
| – | – | ﹤0.01% | 1039 |
|
|
2023
Q2 | $0 | Hold |
407
| – | – | ﹤0.01% | 915 |
|
|
2023
Q1 | $0 | Hold |
407
| – | – | ﹤0.01% | 683 |
|
|
2022
Q4 | $0 | Hold |
407
| – | – | ﹤0.01% | 508 |
|
|
2022
Q3 | $1K | Hold |
407
| – | – | ﹤0.01% | 466 |
|
|
2022
Q2 | $1K | Hold |
407
| – | – | ﹤0.01% | 462 |
|
|
2022
Q1 | $1K | Hold |
407
| – | – | ﹤0.01% | 370 |
|
|
2021
Q4 | $2K | Hold |
407
| – | – | ﹤0.01% | 337 |
|
|
2021
Q3 | $2K | Hold |
407
| – | – | ﹤0.01% | 322 |
|
|
2021
Q2 | $2K | Hold |
407
| – | – | ﹤0.01% | 309 |
|
|
2021
Q1 | $2K | Hold |
407
| – | – | ﹤0.01% | 302 |
|
|
2020
Q4 | $1K | Hold |
407
| – | – | ﹤0.01% | 335 |
|
|
2020
Q3 | $1K | Hold |
407
| – | – | ﹤0.01% | 290 |
|
|
2020
Q2 | $1K | Hold |
407
| – | – | ﹤0.01% | 262 |
|
|
2020
Q1 | $1K | Buy |
+407
| New | +$1.21K | ﹤0.01% | 286 |
|
Other funds holding LXRX
AG
SL
SC
VCM